PDM-35

3,5-dimethyl-2-phenylmorpholine (PDM-35)

Legal status
Legal status	CA: Unscheduled DE: NpSG (Industrial and scientific use only) UK: Under Psychoactive Substances Act US: Analogue to a Schedule I/II drug
Identifiers
IUPAC name 3,5-dimethyl-2-phenylmorpholine
CAS Number	1218345-44-8
PubChem CID	43367115
DrugBank	Provide Please Provide
UNII	B5FRU2US8C
CompTox Dashboard (EPA)	DTXSID801342603
Provide&page2=PDM-35 (verify)

2-Phenyl-3,5-dimethylmorpholine is a drug with stimulant and anorectic effects, related to phenmetrazine. Based on what is known from other phenylmorpholines with similar structure, it likely acts as a norepinephrine-dopamine releasing agent and may produce effects similar or slightly different to phenmetrazine.[1]

See also

• 3-Fluorophenmetrazine
• G-130 (2-Phenyl-5,5-dimethylmorpholine)
• 3,4-Phendimetrazine (2-Phenyl-3,4-dimethylmorpholine)
• 3,6-Phendimetrazine (2-Phenyl-3,6-dimethylmorpholine)
• 4-Methylphenmetrazine
• Manifaxine
• Radafaxine
• Viloxazine

References

1. HU 219458, Boswell GE, Kelley JL, Mehta NB, "2-phenyl-3,5-dimethyl morpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them.", published 28 April 2001, assigned to Wellcome Foundation Ltd.